特异性COX-2抑制剂对小鼠狼疮性肾炎CD14<sup>+</sup>表达及TNF-α、IL-6的影响

钟清; 甘华; 肖刚

doi:10.13406/j.cnki.cyxb.2005.01.020

您当前的位置：

首页 >

文章列表页 >

特异性COX-2抑制剂对小鼠狼疮性肾炎CD14⁺表达及TNF-α、IL-6的影响

更新时间：2024-01-17

- 特异性COX-2抑制剂对小鼠狼疮性肾炎CD14⁺表达及TNF-α、IL-6的影响
- Influence of specific cyclooxygenase-2 inhibitor on TNF-α,IL-6 and expression CD14 positive cells in lupus MRL/lpr mice
- 重庆医科大学学报 2005年第1期页码：71-74
- 作者机构：
  
  1. 重庆医科大学临床学院肾内科
  2. 重庆医科大学临床学院肾内科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2005.01.020
  中图分类号： R593.241
- 纸质出版日期：2005，
扫描看全文
[1]钟清,甘华,肖刚.特异性COX-2抑制剂对小鼠狼疮性肾炎CD14~+表达及TNF-α、IL-6的影响[J].重庆医科大学学报,2005(01):71-74.

ZHONG Qing, et al. Influence of specific cyclooxygenase-2 inhibitor on TNF-α,IL-6 and expression CD14 positive cells in lupus MRL/lpr mice[J]. Journal of Chongqing Medical University, 2005,(1):71-74.
[1]钟清,甘华,肖刚.特异性COX-2抑制剂对小鼠狼疮性肾炎CD14~+表达及TNF-α、IL-6的影响[J].重庆医科大学学报,2005(01):71-74. DOI： 10.13406/j.cnki.cyxb.2005.01.020.

ZHONG Qing, et al. Influence of specific cyclooxygenase-2 inhibitor on TNF-α,IL-6 and expression CD14 positive cells in lupus MRL/lpr mice[J]. Journal of Chongqing Medical University, 2005,(1):71-74. DOI： 10.13406/j.cnki.cyxb.2005.01.020.

摘要

目的探讨特异性COX-2抑制剂对MRL/lpr自发狼疮小鼠的CD14+表达及TNF-α、IL-6的影响。方法用特异性环氧化酶-2（COX-2）抑制剂（Rofecoxib10·kg-1·d-1）治疗12周龄雌性MRL/lpr自发狼疮小鼠

并与未干预组对照。12周后用放射免疫方法检测小鼠血清和尿中肿瘤坏死因子（Tumornecrosisfactor-α

TNF-α）、白细胞介素-6（Interleukin-6

IL-6）及尿血栓索B2（TXB2）的变化;并观察小鼠尿蛋白、血肌酐、肾组织病理改变及CD14+细胞数的变化。结果治疗12周后

治疗组与对照组比较

小鼠血清和尿中TNF-α、IL-6水平降低（P<0.05）;24h尿蛋白排泄量、血肌酐水平及肾组织CD14+细胞数差异均有显著性意义（P<0.05）;肾小球基底膜（GBM）增厚程度差异有显著性意义（P<0.05）。结论特异性COX-2抑制剂治疗MRL/lpr自发狼疮小鼠

可能通过抑制单核/巨噬细胞在肾组织中的浸润

降低血清和尿中TNF-α、IL-6水平

从而减轻了MRL/lpr小鼠肾损害

对LN有较好的治疗作用。

Abstract

Objective:To explore the underlying molecular mechanisms of specific cyclooxygenase-2 inhibitor(Rofecoxib)and to evaluate its efficacy on MRL/lpr mice.Methods:12-week female MRL/lpr mice were given Rofecoxib (10mg·kg -1 ·d -1 )for 12 weeks.Suppressive effect of the drugs on serum and urinary levels of tumor necrosis factor-α(TNF-α)

interleukin-6(IL-6) and urinary TXB 2 level were determined by using radio-immunological assay.Changes in proteinuria

serum creatinine

pathology of ltidney and the expression of CD14 in renal tissues were observed.Results:Compared with the ones in the control group

mice treated with Rofecoxib had lower levels of proteinuria( P <0.01)

serum creatinine( P <0.01)

urinary TXB 2 ( P <0.01)

TNF-α and IL-6( P <0.05) and the thickness of glomerular base membrane (GBM) ( P <0.05).The number of CD14 expression of the positive cells in renal tissue significantly decreased.Conclusion:TNF-α and IL-6 may take part in immune pathogenesis of lupus nephritis(LN).Serum and urinary levels of TNF-α

IL-6 may be useful indicators for monitoring disease degree of renal damage in LN.Rofecoxib may have a significant effect on inhibiting the production of INF-α

IL-6 in the monocytes/macrophages cells.Rofecoxib may decrease the levels of serum and urinary TNF-α

IL-6 and ameliorate renal injuries in lupus MRL/lpr mice.The specific cyclooxygenase-2 inhibitor has a renoprotective effect on MRL-lpr/lpr mice.

关键词

特异性COX-2抑制剂TNF-αIL-6狼疮性肾炎

Keywords

Specific cyclooxygenase-2 inhibitorTumor necrosis factor-αInterleukin-6lupus nephritis

references

浏览量

127

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

狼疮性肾炎患者抗心磷脂抗体的测定及其临床意义

系统性红斑狼疮患者血清骨桥蛋白表达的变化及其临床意义

慢病毒介导的过表达NR4A1单核细胞缓解狼疮小鼠狼疮性肾炎的研究

特异性COX-2抑制剂对小鼠狼疮性肾炎CD14+表达及TNF-α、IL-6的影响

Influence of specific cyclooxygenase-2 inhibitor on TNF-α,IL-6 and expression CD14 positive cells in lupus MRL/lpr mice

DOI：10.13406/j.cnki.cyxb.2005.01.020

摘要

Abstract

关键词

Keywords

references

特异性COX-2抑制剂对小鼠狼疮性肾炎CD14⁺表达及TNF-α、IL-6的影响